Back to Resource Center

Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices

January 2014

Click to view Journal Article

Click for full info +

Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices

Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices
09 January 2014
In this Journal Article:
Health Risk(s):

  • HIV
  • Product Type(s):

  • Microbicides
  • Topic(s):

  • Product Development

  • Full Info:


    Resource Type:

    Journal Article

    Citation:

    Terris-Prestholt, F., Foss, A. M., Cox, A. P., Heise, L., Meyer-Rath, G., Delany-Moretlwe, S., … & Watts, C. H. (2014, January 9). BMC infectious diseases, 14(1), 14.

    Authors:

    Terris-Prestholt, F., Foss, A. M., Cox, A. P., Heise, L., Meyer-Rath, G., Delany-Moretlwe, S., ... & Watts, C. H.

    Health Risks(s):

    • HIV

    Product type(s):

    • Microbicide

    Topic(s):

    • Development

        URL of resource:

        http://www.biomedcentral.com/1471-2334/14/14

        Back to Resource Center